These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC Alzheimers Res Ther; 2020 Mar; 12(1):22. PubMed ID: 32131891 [TBL] [Abstract][Full Text] [Related]
12. Software development for quantitative analysis of brain amyloid PET. Matsuda H; Yamao T Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278 [TBL] [Abstract][Full Text] [Related]
13. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale. Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446 [TBL] [Abstract][Full Text] [Related]
14. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods. Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571 [TBL] [Abstract][Full Text] [Related]
15. Amyloid PET quantification using low-dose CT-guided anatomic standardization. Matsuda H; Yamao T; Shakado M; Shigemoto Y; Okita K; Sato N EJNMMI Res; 2021 Dec; 11(1):125. PubMed ID: 34905145 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858 [TBL] [Abstract][Full Text] [Related]
17. Improved Accuracy of Amyloid PET Quantification with Adaptive Template-Based Anatomic Standardization. Tsubaki Y; Kitamura T; Shimokawa N; Akamatsu G; Sasaki M; J Nucl Med Technol; 2021 Sep; 49(3):256-261. PubMed ID: 33820861 [TBL] [Abstract][Full Text] [Related]
18. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment. Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and acceptance of simultaneous amyloid PET/MRI. Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367 [TBL] [Abstract][Full Text] [Related]
20. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]